Your browser doesn't support javascript.
loading
Preoperative Corticosteroid Injections Demonstrate a Temporal and Dose-Dependent Relationship with the Rate of Postoperative Infection Following Total Hip Arthroplasty.
Forlenza, Enrico M; Burnett, Robert A; Korrapati, Avinaash; Yang, JaeWon; Forsythe, Brian; Della Valle, Craig J.
Afiliação
  • Forlenza EM; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
  • Burnett RA; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
  • Korrapati A; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
  • Yang J; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
  • Forsythe B; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
  • Della Valle CJ; Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty ; 36(6): 2033-2037.e1, 2021 06.
Article em En | MEDLINE | ID: mdl-33618958
ABSTRACT

BACKGROUND:

Corticosteroid injections (CSI) are commonly used for the treatment of osteoarthritis of the hip. There is concern, however, that these injections may increase the risk of postoperative infection if a subsequent total hip arthroplasty (THA) is performed. The purpose of the present investigation is to determine the relationship between CSI and the risk of periprosthetic joint infection (PJI) and surgical site infections (SSIs) following THA.

METHODS:

The PearlDiver database was reviewed for patients undergoing THA from 2011 to 2018. Patients with unilateral hip osteoarthritis who received an intra-articular hip CSI prior to ipsilateral THA were matched in a sequential 11 fashion based on age, gender, and Charlson Comorbidity Index with THA patients who did not receive an injection in the preoperative period. PJI and SSI within 6 months of the surgical procedure were recorded. Statistical analysis included chi-squared test and multivariate logistic regression. Results were considered significant at P < .05.

RESULTS:

In total, 29,058 patients underwent a hip CSI within 6 months prior to THA. CSI within 4 months of surgery was associated with a higher incidence of PJI at 6-month follow up (1.6% vs 1.1%, P = .040). An injection within 1 month of surgery corresponded to a higher odds of PJI (odds ratio [OR] 1.97) than an injection 4 months prior to surgery (OR 1.24). Furthermore, the quantity of CSI administered within the 3 months prior to THA demonstrated a dose-dependent relationship, with each subsequent injection increasing odds of PJI (OR 1.45-3.59). A similar relationship was observed for SSI.

CONCLUSION:

There appears to be both a time and dose-dependent association of hip CSI and PJI following THA. Surgeons should consider delaying elective THA if a CSI has been administered within the 4 months prior to the planned procedure.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Infecciosa / Infecções Relacionadas à Prótese / Artroplastia de Quadril Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Infecciosa / Infecções Relacionadas à Prótese / Artroplastia de Quadril Idioma: En Ano de publicação: 2021 Tipo de documento: Article